Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Illumina (ILMN)
NASDAQ:ILMN
ILMN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$99.33 - $156.66
Previous CloseN/A
Volume388.94K
Average Volume (3M)2.51M
Market Cap
$16.01B
Enterprise Value$23.05B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.52
Next Earnings
May 01, 2025EPS Estimate
0.96Last Dividend Ex-Date
Jun 25, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-7.72
Shares Outstanding158,400,000
10 Day Avg. Volume3,854,472
30 Day Avg. Volume2,507,648
Standard Deviation0.12
R-Squared0.25
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.66
Price to Cash Flow (P/CF)11.00
P/FCF Ratio11.00
Enterprise Value/Market Cap1.44
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.05
Enterprise Value/Ebitda-31.79
Forecast
1Y Price Target
$149.83Price Target Upside45.47% Upside
Rating ConsensusHold
Number of Analyst Covering14
---
Bulls Say, Bears Say
Bulls Say
Product InnovationManagement believes ILMN remains on track for roughly 75% of high-throughput gigabases shipped to transition to the NovaSeq X series.
Bears Say
China Market ChallengesThe upcoming exit from China is seen as inevitable, impacting revenue projections.
Market CompetitionFacing stiff competition from BGI/MGI in China, ILMN has limited avenues to grow in this market.
---
Ownership Overview
0.23% Insiders
27.97% Mutual Funds
39.57% Other Institutional Investors
10.24% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ILMN FAQ
What was Illumina’s price range in the past 12 months?
Illumina lowest stock price was $99.33 and its highest was $156.66 in the past 12 months.
What is Illumina’s market cap?
Illumina’s market cap is $16.01B.
When is Illumina’s upcoming earnings report date?
Illumina’s upcoming earnings report date is May 01, 2025 which is in 70 days.
How were Illumina’s earnings last quarter?
Illumina released its earnings results on Feb 06, 2025. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.913 by $0.037.
Is Illumina overvalued?
According to Wall Street analysts Illumina’s price is currently Undervalued.
Does Illumina pay dividends?
Illumina pays a Notavailable dividend of $3.104 which represents an annual dividend yield of N/A. See more information on Illumina dividends here
What is Illumina’s EPS estimate?
Illumina’s EPS estimate is 0.96.
How many shares outstanding does Illumina have?
Illumina has 158,400,000 shares outstanding.
What happened to Illumina’s price movement after its last earnings report?
Illumina reported an EPS of $0.95 in its last earnings report, beating expectations of $0.913. Following the earnings report the stock price went down -9.56%.
Which hedge fund is a major shareholder of Illumina?
Currently, no hedge funds are holding shares in ILMN
---
Illumina Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$149.83 (45.47% Upside)
$149.83 (45.47% Upside)
Blogger Sentiment
Bullish
ILMN Sentiment 83%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 677.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 9.5%
Last 30 Days ▲ 9.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.09%
12-Months-Change
Fundamentals
Return on Equity
-51.54%
Trailing 12-Months
Asset Growth
-37.66%
Trailing 12-Months
Company Description
Illumina
Incorporated in 1998, Illumina, Inc. is a California-based company which develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting.
---
ILMN Company Deck
---
ILMN Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with notable achievements in revenue growth and strategic partnerships but also highlighted challenges, particularly in the China market and a decline in certain regional revenues.Read More>---
ILMN Revenue Breakdown
91.33% Sequencing
8.67% Microarray
---
ILMN Stock 12 Month Forecast
Average Price Target
$149.83
▲(45.47% Upside)
Technical Analysis
Pacific Biosciences
―
Qiagen
―
Crispr Therapeutics AG
―
Guardant Health
―
Twist Bioscience
―
Best Analysts Covering ILMN
1 Year
1 Year Success Rate
23/30 ratings generated profit
1 Year Average Return
+17.88%
reiterated a buy rating 9 months ago
Copying Doug Schenkel's trades and holding each position for 1 Year would result in 76.67% of your transactions generating a profit, with an average return of +17.88% per trade.
---